Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms

Key Findings:  This mouse study of Autism-like behavior found that administration of palmitoylethanolamide (PEA) reduced symptoms of Autism, and further supports evidence of PEA's neuroprotective and anti-inflammatory effects.

Type of Study:  Animal Study

Study Result:  Positive

Study Location(s):  Italy

Year of Pub:  2018

Cannabinoids Studied:  Palmitoylethanolamide (PEA)

Phytocannabinoid Source:  Not Applicable

Receptors Studied:  PPAR - Alpha

Dosage: PEA (10 or 30 mg/kg)

Route of Administration:  Injection

Link to study